Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

SLNO holding history

Soleno Therapeutics Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SLNO overviewAll 13F holders of SLNOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
16
Since Q1 2021
Holdings of SLNO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−225,147−100.0%Sold outHolders
Q1 2026225,147$7.54M<0.1%+55,641+32.8%AddedHolders
Q4 2025169,506$7.85M<0.1%+11,198+7.1%AddedHolders
Q3 2025158,308$10.7M<0.1%+52,312+49.4%AddedHolders
Q2 2025105,996$8.88M<0.1%+48,519+84.4%AddedHolders
Q1 202557,477$4.11M<0.1%+7,322+14.6%AddedHolders
Q4 202450,155$2.25M<0.1%+5,490+12.3%AddedHolders
Q3 202444,665$2.26M<0.1%+10,715+31.6%AddedHolders
Q2 202433,950$1.39M<0.1%−19,855−36.9%ReducedHolders
Q1 202453,805$2.30M<0.1%+36,017+202.5%AddedHolders
Q4 202317,788$716.0K<0.1%+17,788NewHolders
Q3 20230$00.0%−15−100.0%Sold outHolders
Q2 202315$64<0.1%+15NewHolders
Q3 20220$00.0%−3,646−100.0%Sold outConverted for a 1-for-15 splitHolders
Q2 202254,695$10.0K<0.1%+54,695NewHolders
Q1 20220$00.0%−30,211−100.0%Sold outHolders
Q4 202130,211$12.0K<0.1%+13,905+85.3%AddedHolders
Q3 202116,306$15.0K<0.1%+15,344+1,595.0%AddedHolders
Q2 2021962$1.00K<0.1%−36,014−97.4%ReducedHolders
Q1 202136,976$47.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.